Oxford Cannabinoid Technologies Company
OCT is a biopharmaceutical company established to combine cannabinoid medicine with world class scientific research.
Technology:
Small Molecules
Industry:
PharmTech
Headquarters:
Oxford, Oxfordshire, United Kingdom
Founded Date:
2017
Employees Number:
11-50
Funding Status:
IPO
Estimated Revenue:
$1M to $10M
Register and Claim Ownership